INTELLIA THERAPEUTICS INC (NTLA) Institutional Shareholders
INTELLIA THERAPEUTICS INC (NTLA) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $2.44B in NTLA holdings during the latest filing period.
ARK Invest is currently the largest disclosed institutional shareholder of NTLA tracked by InsiderSet, reporting ownership valued at approximately $285.54M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $206.90M, representing an estimated loss of -27.54% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 55% of the total disclosed NTLA value among the investors covered in this analysis. Major shareholders include ARK Invest, Blackrock, Inc., State Street Corp, and several other long-term asset managers with concentrated positions in INTELLIA THERAPEUTICS INC (NTLA).
This page ranks the largest institutional NTLA shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
319
Total Reported Value
$2.44B
Largest Holder
ARK Invest
Largest Position
$285.54M
Insider Transactions (90d)
5
Latest Filing Quarter
Q2 2026
New Institutional Positions
49
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| ARK Invest | Cathie Wood | 1.85% | 16,875,684 | $285,536,575 | $206,895,886 | -$78,640,689 | -27.54% |
| Blackrock, Inc. | 0.00% | 15,409,023 | $260,720,664 | $188,914,622 | -$71,806,042 | -27.54% | |
| State Street Corp | 0.00% | 9,234,987 | $156,255,980 | $113,220,941 | -$43,035,039 | -27.54% | |
| Vanguard Portfolio Management Llc | 0.01% | 7,332,401 | $124,064,225 | $89,895,236 | -$34,168,989 | -27.54% | |
| D. E. Shaw & Co., Inc. | 0.07% | 6,443,323 | $109,021,025 | $78,995,140 | -$30,025,885 | -27.54% | |
| Vanguard Capital Management Llc | 0.00% | 6,028,586 | $102,003,675 | $73,910,464 | -$28,093,211 | -27.54% | |
| Two Sigma Investments, Lp | 0.07% | 5,235,348 | $88,582,088 | $64,185,366 | -$24,396,722 | -27.54% | |
| Fmr Llc | 0.00% | 4,773,034 | $80,759,741 | $58,517,397 | -$22,242,344 | -27.54% | |
| Ra Capital Management, L.P. | 0.67% | 4,526,926 | $76,595,588 | $55,500,113 | -$21,095,475 | -27.54% | |
| Regeneron Pharmaceuticals, Inc. | 35.35% | 3,702,995 | $62,654,675 | $45,398,719 | -$17,255,956 | -27.54% | |
| Geode Capital Management, Llc | 0.00% | 3,631,061 | $61,449,402 | $44,516,808 | -$16,932,594 | -27.56% | |
| Arrowstreet Capital, Limited Partnership | 0.02% | 3,280,760 | $55,510,459 | $40,222,118 | -$15,288,341 | -27.54% | |
| Amova Asset Management Americas, Inc. | 0.63% | 2,897,529 | $49,026,191 | $35,523,706 | -$13,502,485 | -27.54% | |
| Sumitomo Mitsui Trust Group, Inc. | 0.03% | 2,897,529 | $49,026,191 | $35,523,706 | -$13,502,485 | -27.54% | |
| Dimensional Fund Advisors Lp | 0.01% | 2,602,944 | $44,038,979 | $31,912,093 | -$12,126,886 | -27.54% | |
| Goldman Sachs Group Inc | 0.00% | 2,264,471 | $38,314,849 | $27,762,414 | -$10,552,435 | -27.54% | |
| Ubs Group Ag | 0.01% | 2,152,912 | $36,427,270 | $26,394,701 | -$10,032,569 | -27.54% | |
| Voloridge Investment Management, Llc | 0.15% | 2,066,356 | $34,962,744 | $25,333,525 | -$9,629,219 | -27.54% | |
| Contrarius Group Holdings Ltd | 1.52% | 1,955,228 | $33,082,458 | $23,971,095 | -$9,111,363 | -27.54% | |
| Jupiter Asset Management Ltd | 0.16% | 1,849,507 | $31,293,658 | $22,674,956 | -$8,618,702 | -27.54% | |
| Morgan Stanley | 0.00% | 1,731,905 | $29,303,849 | $21,233,155 | -$8,070,694 | -27.54% | |
| Armistice Capital, Llc | 0.70% | 1,500,000 | $25,380,000 | $18,390,000 | -$6,990,000 | -27.54% | |
| Renaissance Technologies LLC | Jim Simons | 0.03% | 1,400,004 | $23,688,068 | $17,164,049 | -$6,524,019 | -27.54% |
| Northern Trust Corp | 0.00% | 1,272,136 | $21,524,541 | $15,596,387 | -$5,928,154 | -27.54% | |
| Hrt Financial Lp | 0.04% | 1,243,317 | $21,036,000 | $15,243,066 | -$5,792,934 | -27.54% | |
| Charles Schwab Investment Management Inc | 0.00% | 1,207,941 | $20,438,362 | $14,809,357 | -$5,629,005 | -27.54% | |
| Ghisallo Capital Management Llc | 0.40% | 1,200,000 | $20,304,000 | $14,712,000 | -$5,592,000 | -27.54% | |
| Woodline Partners Lp | 0.06% | 1,075,349 | $18,194,905 | $13,183,779 | -$5,011,126 | -27.54% | |
| Stifel Financial Corp | 0.01% | 1,014,387 | $17,163,415 | $12,436,385 | -$4,727,030 | -27.54% | |
| Bank Of America Corp | 0.00% | 976,216 | $16,517,576 | $11,968,408 | -$4,549,168 | -27.54% | |
| Baker Bros. Advisors Lp | 0.08% | 930,232 | $15,739,525 | $11,404,644 | -$4,334,881 | -27.54% | |
| Vanguard Fiduciary Trust Co | 0.00% | 921,121 | $15,585,367 | $11,292,943 | -$4,292,424 | -27.54% | |
| Connor, Clark & Lunn Investment Management Ltd. | 0.03% | 898,963 | $15,210,454 | $11,021,286 | -$4,189,168 | -27.54% | |
| Iq Eq Fund Management (Ireland) Ltd | 0.84% | 777,948 | $13,162,880 | $9,537,642 | -$3,625,238 | -27.54% | |
| Jacobs Levy Equity Management, Inc | 0.04% | 726,057 | $12,284,884 | $8,901,459 | -$3,383,425 | -27.54% | |
| Federated Hermes, Inc. | 0.02% | 725,970 | $12,283,412 | $8,900,392 | -$3,383,020 | -27.54% | |
| Raymond James Financial Inc | 0.00% | 699,390 | $11,833,679 | $8,574,521 | -$3,259,158 | -27.54% | |
| Royal Bank Of Canada | 0.00% | 673,340 | $11,394,000 | $8,255,148 | -$3,138,852 | -27.55% | |
| Susquehanna International Group, Llp | 0.01% | 647,679 | $10,958,729 | $7,940,545 | -$3,018,184 | -27.54% | |
| Marex Group Plc | 0.09% | 623,600 | $10,551,312 | $7,645,336 | -$2,905,976 | -27.54% | |
| Bnp Paribas Financial Markets | 0.01% | 577,825 | $9,776,799 | $7,084,135 | -$2,692,665 | -27.54% | |
| Vestmark Advisory Solutions, Inc. | 0.08% | 532,817 | $9,015,264 | $6,532,336 | -$2,482,928 | -27.54% | |
| Jpmorgan Chase & Co | 0.00% | 527,662 | $8,867,081 | $6,469,136 | -$2,397,945 | -27.04% | |
| Aqr Capital Management Llc | 0.00% | 492,954 | $8,340,783 | $6,043,616 | -$2,297,167 | -27.54% | |
| Millennium Management Llc | 0.01% | 491,226 | $8,311,544 | $6,022,431 | -$2,289,113 | -27.54% | |
| Invesco Ltd. | 0.00% | 412,010 | $6,971,209 | $5,051,243 | -$1,919,966 | -27.54% | |
| Bank Of New York Mellon Corp | 0.00% | 410,654 | $6,948,265 | $5,034,618 | -$1,913,647 | -27.54% | |
| Birchview Capital, Lp | 3.17% | 385,900 | $6,780,968 | $4,731,134 | -$2,049,834 | -30.23% | |
| Point72 Asset Management, L.P. | 0.01% | 398,463 | $6,741,994 | $4,885,156 | -$1,856,838 | -27.54% | |
| Nuveen, Llc | 0.00% | 377,646 | $6,389,770 | $4,629,940 | -$1,759,830 | -27.54% |
Frequently asked questions about NTLA
Who owns the most NTLA stock?
The largest holders of NTLA are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for INTELLIA THERAPEUTICS INC (NTLA).
Is NTLA widely held by superinvestors?
Many widely followed stocks like NTLA appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly NTLA is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.